ENANTIOMERICALLY PURE beta -D-DIOXOLANE-NUCLEOSIDES

A method and composition for the treatment of humans infected with HIV that includes the administration of an HIV treatment amount of an enantiomerically pure (beta)-D-dioxolanyl purine nucleoside of formula (I), wherein R is OH, Cl, NH2, or H, or a pharmaceutically acceptable salt or derivative of the compound, optionally in a pharmaceutically acceptable carrier or diluent.

Attached files:
AT 498624.jpg

Patents:
AT 498,624

Inventor(s): CHU CHUNG K [US]; SCHINAZI RAYMOND F [US]

Type of Offer: Licensing



Next Patent »
« More Pharmaceutical Patents

Share on      


CrowdSell Your Patent